SIC 2835 – In Vitro and In Vivo Diagnostic Substances
Valuation | |
---|---|
Market Cap ($M) | 18.19 |
Enterprise Value ($M) | 16.21 |
Book Value ($M) | 3.69 |
Book Value / Share | 0.09 |
Price / Book | 4.94 |
NCAV ($M) | 1.83 |
NCAV / Share | 0.05 |
Price / NCAV | 9.93 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.87 |
Return on Assets (ROA) | -1.85 |
Return on Equity (ROE) | -2.79 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 8.51 |
Current Ratio | 8.51 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 2.63 |
Assets | 4.48 |
Liabilities | 0.80 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Shares Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | BlackRock, Inc. | 4.90 | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
209,575 | 613,421 | 34.16 | |
249,051 | 717,241 | 34.72 | |
297,147 | 1,047,406 | 28.37 | |
1,175,902 | 3,174,049 | 37.05 | |
640,989 | 1,607,189 | 39.88 | |
(click for more detail) |
Similar Companies | |
---|---|
CAPR – Capricor Therapeutics, Inc. | CARA – Cara Therapeutics, Inc. |
CASI – CASI Pharmaceuticals, Inc. | CDMO – Avid Bioservices, Inc. |
CDTX – Cidara Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io